Cardiovascular-Kidney-Metabolic (CKM) syndrome recognizes the interconnected relationship among cardiovascular disease, kidney disease, obesity, diabetes, and other metabolic risk factors that contribute to long-term health outcomes. The first-ever CKM clinical practice guideline introduces a framework for risk assessment, staging, prevention, and management, emphasizing early identification and coordinated care across disease states. You will be better prepared to recognize CKM syndrome, understand its implications for patient care, and support evidence-based strategies to reduce cardiovascular, kidney, and metabolic risk.
HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact
GUEST
Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
Professor, Pharmacy Practice and Clinical Pharmacist
Midwestern University
GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
Purchase Now!
PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the stages and key components of cardiovascular-kidney-metabolic syndrome.
2. Explain evidence-based strategies for identifying and managing patients at risk for CKM syndrome.
Christine Schumacher is a Speaker and Advisory Board Member for Abbott. All relevant financial relationships have been mitigated.
0.075 CEU/0.75 Hr
UAN: 0107-0000-26-315-H01-P
Initial release date: 8/31/2026
Expiration date: 8/31/2029
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram
